Article
Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSC
2021-09-06
Abstract excerpt
Recombinant adeno-associated virus (AAV) is the most widely used vector for gene therapy in clinical trials. To increase transduction efficiency and specificity, novel engineered AAV variants with modified capsid sequences are evaluated in human cell cultures and non-human primates. In the present study, we tested two novel AAV capsid variants, AAV2-NNPTPSR and AAV9-NVVRSSS, in human cortical neurons, which were d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c561f8d8-90cc-5e10-95e1-aa56019469e5
- DOI
- 10.1101/2021.09.06.459070
